Early intervention can significantly improve the development and prognosis of
T1DM, and effective biomarkers are great significance for the early prediction
and diagnosis of T1DM. As a diabetes focused solution provider, Ace
Therapeutics has established a multi-functional CRO platform service. We can
provide researchers engaged in biomarker development of diabetes with more
efficient function analysis.
https://www.acetherapeutics.com/diabetes/t1dm-biomarker-development-service.html
_______________________________________________
Wikipedia-ne mailing list -- [email protected]
To unsubscribe send an email to [email protected]
